Nationwide Cohort study on the development of diagnosis and treatment of pheochromocytoma in Japan

Nationwide Cohort study on the development of diagnosis and treatment of pheochromocytoma in Japan - PHEO-J

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004151

Enrollment

2500

Registered

2010-09-03

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pheochromocytoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pheochromocytoma who visited outpatient clinics and hospitals during April 1, 2008 to March 31, 2012

Exclusion criteria

Exclusion criteria: 1)patients not visited during the specified period. 2)patients treated at those specified outpatients clinics and hospitals. 3)patient who does not full-fill the diagnostic criteria.

Design outcomes

Primary

Measure	Time frame
1.Elucidation of the therapeutic effects and prognosis by establishing disease registry. 2. Establishment of the early diagnostic method by central analysis of histopathological markers.	—

Secondary

Measure	Time frame
Improvement of the prognosis of pheochromocytoma	—

Countries

Japan

Contacts

Public ContactMitsuhide Naruse

National Hospital Organization, Kyoto Medical Center Department of Endocrinology, Clinical Research Institute for Endocrine and Metabolic Diseases

mnaruse@kyotolan.hosp.go.jp075-641-9161

Outcome results